A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects
Titel:
A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects
Auteur:
Cohen-Barak, Orit Weiss, Sivan Rasamoelisolo, Michele Faulhaber, Nicola Yeung, Paul P Loupe, Pippa S Yoon, Esther Gandhi, Mohit D Spiegelstein, Ofer Aycardi, Ernesto